Crossref
B-ALL with synchronous MYC and BCL-2 rearrangement
Blood · 2023
DOI: 10.1182/blood.2022019067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Michel Attieh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Emory University. Hauptthemen laut MEDLINE: Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Burkitt LymphomaLymphoma, Large B-Cell, DiffuseHumansGenes, mycProto-Oncogene Proteins c-bcl-2Gene RearrangementProto-Oncogene Proteins c-myc
Substanzen
Proto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-myc
Autor:innen und Institutionen
- Emory University.
ORCID-Profile: Saja Asakrah
Zitieren
APA
Attieh, M., & Asakrah, S. (2023). B-ALL with synchronous MYC and BCL-2 rearrangement. Blood. https://doi.org/10.1182/blood.2022019067
Vancouver
Attieh M, Asakrah S. B-ALL with synchronous MYC and BCL-2 rearrangement. Blood. 2023. doi:10.1182/blood.2022019067
BibTeX
@article{Attieh2023,
author = {Attieh, Michel and Asakrah, Saja},
title = {B-ALL with synchronous MYC and BCL-2 rearrangement},
journal = {Blood},
year = {2023},
doi = {10.1182/blood.2022019067}
}
EUVIMED